Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02393443Phase 1Completed
Phase 1, randomised, double-blind trial of oxytocin nasal spray (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Changes in brain neural activity. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02393443.